• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$70.30 $0.00 (0.00%)

REAL-TIME: Last trade at

Medco Health Solutions

NYSE:MHS

Nordstrom, Express Scripts results due after hours

2 Companies You Should Run Away From

This Sector Favors No Investor

Catalyst, SXC surge on merger disclosure

Is Walgreen Dead Without Express Scripts?

Media Digest (4/3/2012) Reuters, WSJ, NYT, FT

Company News for April 3, 2012 - Corporate Summary

Management Churn at CVS Caremark - Analyst Blog

Express-Medco Marriage to Get FTC's Blessing

The Zacks Analyst Blog Highlights: Supervalu, Medco Health Solutions, Express Scripts, Walgreen and

Merger Watchdogs Asleep in Medco-Express PBM Merger? (MHS, ESRX)

Comeback Stock: Express Scripts Kicked Walgreens’ Tail and Now Seeks to Close a Big Merger

CORRECT: US Stocks End At Multiyear Highs On US Manufacturing Report

CORRECT: Medco Executives Paid Max 2011 Bonuses; Express Scripts More Frugal

Opposition to PBM Merger Already Speaks Out! (ESRX, MHS)

Medco-ESRX Deal Irks Supervalu - Analyst Blog

US Pharmacy Groups Seek Temporary Restraining Order Vs Deal

Pharmacy Groups File Suit Against Express Scripts, Medco Deal

ESRX-MHS to Merge Next Week - Analyst Blog

UPDATE: Pharmacy Groups File Suit Against Express Scripts, Medco Deal

Here's What the World's Oldest Investor Is Buying

Express Scripts, Medco Say Deal Could Close Next Week

2nd UPDATE: Walgreen 2Q Profit Falls 7.7% On Express Scripts Exit

Walgreen Sees Flexibility To Keep Medco Clients If Merger Wins Approval

Medco To Pay $2.8 Million To Resolve CalPERS Payment Probe

UPDATE: Medco To Pay $2.8 Million To Resolve CalPERS Payment Probe

Balanced View on Express Scripts - Analyst Blog

Medco Reiterated at Neutral - Analyst Blog

Express Scripts/Medco Deal Could Face State Lawsuits -Bloomberg

What If Walgreen buys Rite-Aid?

The Huge Merger That Shouldn't Happen

Medco-Quest Fix Study Result Date - Analyst Blog

ESRX-MHS to Merge Next Quarter - Analyst Blog

Company News for March 12, 2012 - Corporate Summary

CVS' New "Pharmacy Home" Plan - Analyst Blog

Top Analyst Upgrades & Downgrades (AAPL, ADP, ESRX, GGP, KFT, LULU, MHS, MCO, P, PG, VRSK, VRML)

Is Medco's Growth for Real?

CVS Caremark Remains Neutral - Analyst Blog

CVS Says Tailwinds Favor PBM-Retail Hybrid Business Model

2 of the Market's Most-Hated Stocks

See More Articles...